NIH: Mix-And-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic
January 29, 2022
January 29, 2022
WASHINGTON, Jan. 29 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on Jan. 26, 2022:
* * *
NIH-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine
* * *
In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Dr . . .
* * *
NIH-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine
* * *
In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Dr . . .